We seek a highly motivated Scientist to lead biomarker development efforts in support of Genentech’s Late Stage Oncology Biomarker pipeline within Development Sciences. Substantial expertise in oncology, cancer cell signaling pathways, including the MAPK and PI3K pathways, cancer immunotherapy and translational research is highly desirable. The ideal candidate will also be familiar with methodologies and platforms used for analyzing high-content NGS data. The incumbent will be responsible for designing, implementing and leading the biomarker strategy for Genentech’s Late Stage Oncology products. The successful candidate is expected to work seamlessly as part of a multifunctional team, have excellent oral and written communication skills, participate and contribute to team meetings, publish in high quality scientific, technical or medical journals, present at internal and external meetings.
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
Genentech makes life-saving medicine. People make Genentech what it is. This video offers insights into who these people are and what it means to them to be working at Genentech.